Stockreport

Bellicum Pharmaceuticals Announces Presentation on CAR-NK Cell Program at SITC 2019

Bellicum Pharmaceuticals, Inc.  (BLCM) 
Last bellicum pharmaceuticals, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.bellicum.com/investor-overview
PDF HOUSTON, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancer [Read more]